Biotech

AI Meets Life Sciences: How HKSTP and BioMap Are Transforming Hong Kong’s Biotech Landscape

In an exclusive interview with BioPharma APAC, Dr. Grace Lau, Head of Institute for Translational Research at Hong Kong Science and Technology Parks Corpor...

 August 14, 2024 | Interview

Thermo Fisher's SeCore™ CDx HLA A Sequencing System Gains FDA Clearance for Use with Adaptimmune’s New TCR Therapy

Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(...

 August 07, 2024 | News

Twist Bioscience and bitBiome Launch Innovative Transaminase Enzyme Screening Kit for Pharmaceutical Synthesis

Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its sili...

 August 06, 2024 | News

Biosyngen and A*STAR Forge Strategic Alliance to Advance Autoimmune Therapies

Biosyngen has announced a strategic collaboration with Singapore's Agency for Science, Technology and Research (A*STAR) to enhance autoimmune the...

 August 02, 2024 | News

Thermo Fisher Scientific and BioCell Innovations Sign MoU to Optimize Lentiviral-Based Immunotherapy Manufacturing in Asia-Pacific

  Thermo Fisher Scientific, a global leader in serving science, is excited to announce the signing of a Memorandum of Understanding (MoU) with BioCel...

 July 19, 2024 | News

Aptamer Group's CTO Arron Tolley Discusses Strategic Milestones and Innovations in Collaboration with AstraZeneca

  In an exclusive interview with BioPharma APAC, Arron Tolley, Chief Technology Officer of Aptamer Group, shares insights on the company's latest col...

 July 11, 2024 | News

Advancing Cancer Care: The Promise and Potential of CAR-T Therapy

  In an interaction with BioPharma APAC, Anuradha Rajapakse, Senior Director for Value & Access at Gilead and Kite Oncology, This discussion...

 June 28, 2024 | Interaction

Merck Halts Phase III TrilynX Study for Xevinapant in Head and Neck Cancer Following Interim Analysis

Merck, a leading science and technology company, announced the discontinuation of the Phase III randomized TrilynX study evaluating xevinapant plus chemora...

 June 25, 2024 | News

Thermo Fisher Scientific, NUH, and Mirxes Collaborate to Enhance Access to Advanced Genomic Cancer Testing in Singapore

To increase patient access to affordable, advanced genomic testing for cancer in Singapore, Thermo Fisher Scientific Inc., the world leader in serving scie...

 June 14, 2024 | News

NSG BioLabs Partners with Eppendorf to Propel Biotech Startups in Singapore

Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the start...

 June 13, 2024 | News

Merck Opens Expanded Life Science Distribution Center in Germany

Expands facility by 25,000 square meters, nearly doubling size Adds new down filling capabilities and distribution space for Life Science customers Emp...

 June 07, 2024 | News

Overcoming Vaccine Access Challenges in Asia Pacific: Perspectives from DKSH's Reuben Ong

  Timely access to vaccines is crucial for public health, especially in regions with diverse regulatory landscapes like the Asia Pacific. Bio...

 May 17, 2024 | Interview

Sartorius Teams Up with Sanofi to Pioneer Next-Generation Biomanufacturing Platform

Sartorius selected as preferred partner for development and commercialization of integrated and continuous biomanufacturing (ICB) platform Modular pl...

 May 14, 2024 | News

NSG BioLabs Secures $14.5 Million Investment, Expands Partnerships to Bolster Singapore's Biotech Ecosystem

  NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investme...

 May 08, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close